• Nenhum resultado encontrado

Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers

N/A
N/A
Protected

Academic year: 2021

Share "Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers"

Copied!
12
0
0

Texto

Loading

Imagem

Figure S2). Unsupervised hierarchical clustering, using the same 209 CpG probes, revealed the existence of two
Fig. 2 209 CpG probes are correlated with cognate gene expression. a Stacked bar plot showing localization of differentially-methylated CpG sites within their cognate genes subdivided by the correlation between methylation change and expression change
Fig. 3 OncoScore of the “ top 7 ” (green) and “ bottom 7 ” (red) genes
Fig. 4 Epigenetic analysis of CpGs sites from PRAC2 , TDRD10 and TMEM132C ( “ bottom 7 ” genes)
+2

Referências

Documentos relacionados

However, this book was reviewed in 1994 and 2001 with the purpose to include the arising ethical issues outside professional settings, and that is clearly seen in her

Nos grupos com uma média de ingestão igual ou superior ao AI pode assumir-se que existe uma baixa prevalência de inadequação para um dado nutriente, no entanto

XRCC1 Arg399Gln and RAD51 50UTR G135C polymorphisms and their outcome in tumor aggressiveness and survival of Portuguese breast cancer patients. Breast Cancer

his study had two objectives: irst, to immunohistochemically analyze the expression of CD83 in human breast ibroadenoma cells and adjacent normal breast tissue; and

Entre outros, foram usadas 8 escalas do Children Behavior Questionnaire (CBQ) de Rothbart (Rothbart & Ahadi, 1994) para avaliar características do temperamento

MiRNA expression and DNA methylation changes were also investigated in FACS sorted CD44 high oral cancer stem cells from primary tumor samples (CSCs), and in oral rinse.. and

Increased expression of Rev3 in human breast epithelial cancer cell lines compared to non- neoplastic human breast epithelial cells MCF-12A, and in human breast tumors compared

(a) Western blot analysis using UBE4B-specific antibodies showing UBE4B protein expression in normal breast tissues and in breast cancer tissues (C: breast cancer tissue; N: